Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_468ba69b8e2068e9319b9942dcc081b3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate |
2001-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2003-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0826417b9db3b5f0739c7319b8c0bc7b |
publicationDate |
2003-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6555656-B2 |
titleOfInvention |
Covalent modification of abnormal prion protein |
abstract |
A prion-physiological structure and associated method of formation. A provided abnormal prion has a transforming power over a normal prion to convert the abnornal prion into defective prion that mimics the abnormal prion. A linker molecule is then bonded to the abnormal prion, wherein a polymer that is covalently attached to the linker molecule facilitates formation of a polymerized abnormal prion that does not have the transforming power over the normal prion. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100881636-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964339-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008193430-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8067151-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009041737-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004058873-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100849422-B1 |
priorityDate |
2001-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |